Login / Signup

Temporal trends in heart failure medication prescription in a population-based cohort study.

Alicia UijlIlonca VaartjesS DenaxasHarry HemingwayAnoop ShahJ ClelandDiederick GrobbeeArno HoesFolkert W AsselbergsStefan Koudstaal
Published in: BMJ open (2021)
In the general population, the use of MR-antagonists for HF remained low and did not change throughout 13 years of follow-up. For most patients, few changes were seen in pharmacological management of HF in the 6 months following diagnosis.
Keyphrases
  • heart failure
  • end stage renal disease
  • acute heart failure
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • healthcare
  • peritoneal dialysis
  • magnetic resonance
  • computed tomography
  • patient reported